Komori
Revision to earnings forecasts4182Mitsubishi Gas Chemical Company,Inc.Materials and Chemicals

Notice Regarding Revisions to Earnings Forecasts

The full-year consolidated forecast for the fiscal year ending March 2027 was revised upward for revenue, operating profit, ordinary profit and net income. The standalone full-year forecast was revised upward for revenue and ordinary profit, while the operating profit forecast was left unchanged and the net income forecast was revised downward.

Worth reading
75Important
Scored from 4 of 5 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
40000
¥ million
Wording
Conditional
How definitive the wording is.

Revised forecast

Fiscal year ending March 2027 · Full yearPrevious forecast published 7 August 2026
Net SalesConsolidated860,000→900,000million
+4.7%
Net SalesIndividual510,000→540,000million
+5.9%
Operating profitConsolidated71,000→81,000million
+14.1%
Operating profitIndividual31,000→31,000million
0.0%
Ordinary incomeConsolidated79,000→96,000million
+21.5%
Ordinary incomeIndividual46,000→47,000million
+2.2%
Profit attributable to owners of the parentConsolidated55,000→65,000million
+18.2%
Profit attributable to owners of the parentIndividual38,000→36,000million
-5.3%
Net income per shareConsolidated282.04→333.32Yen
+18.2%
Net income per shareIndividual194.86→184.61Yen
-5.3%

The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.

Reason for the revision

Consolidated revenue and each profit measure are expected to exceed the previous forecast due to the sustained high prices of crude oil and methanol, improved profitability from passing higher costs through to engineering plastics prices, the effects of price revisions for BT materials used in semiconductor package substrates, and higher sales volumes of chemicals for semiconductors. On a standalone basis, revenue is expected to increase due to the sustained high prices of crude oil and methanol, but net income is expected to fall below the previous forecast because the company recognized a valuation loss on shares in a Dutch subsidiary that manufactures meta-xylylenediamine during the interim accounting period, among other factors.

Details and amount of extraordinary loss

A valuation loss was recognized on shares in a Dutch subsidiary that manufactures meta-xylylenediamine. The amount was not disclosed.

Previous-period resultsConsolidated Revenue ¥738,243 million, operating profit ¥45,293 million, ordinary profit ¥51,947 million, net income attributable to owners of the parent -¥40,318 million, earnings per share -¥207.04 / Individual Revenue ¥407,509 million, operating profit ¥16,115 million, ordinary profit ¥35,834 million, net income -¥47,080 million, earnings per share -¥241.77
Consolidated / non-consolidatedConsolidated/non-consolidated
Revised forecast
ItemDetails
Net SalesConsolidated 860,000 / Individual 510,000 → Consolidated 900,000 / Individual 540,000(Consolidated 4.7 / Individual 5.9)
Operating profitConsolidated 71,000 / Individual 31,000 → Consolidated 81,000 / Individual 31,000(Consolidated 14.1 / Individual Not disclosed)
Ordinary incomeConsolidated 79,000 / Individual 46,000 → Consolidated 96,000 / Individual 47,000(Consolidated 21.5 / Individual 2.2)
Profit attributable to owners of the parentConsolidated 55,000 / Individual 38,000 → Consolidated 65,000 / Individual 36,000(Consolidated 18.2 / Individual -5.3)
Net income per shareConsolidated 282.04 / Individual 194.86 → Consolidated 333.32 / Individual 184.61
Fiscal Period CoveredFiscal year ending March 2027
Period CoveredFull year
Publication date of previous forecast7 August 2026
Previous-period resultsConsolidated Revenue ¥738,243 million, operating profit ¥45,293 million, ordinary profit ¥51,947 million, net income attributable to owners of the parent -¥40,318 million, earnings per share -¥207.04 / Individual Revenue ¥407,509 million, operating profit ¥16,115 million, ordinary profit ¥35,834 million, net income -¥47,080 million, earnings per share -¥241.77
Reason for the revisionConsolidated revenue and each profit measure are expected to exceed the previous forecast due to the sustained high prices of crude oil and methanol, improved profitability from passing higher costs through to engineering plastics prices, the effects of price revisions for BT materials used in semiconductor package substrates, and higher sales volumes of chemicals for semiconductors. On a standalone basis, revenue is expected to increase due to the sustained high prices of crude oil and methanol, but net income is expected to fall below the previous forecast because the company recognized a valuation loss on shares in a Dutch subsidiary that manufactures meta-xylylenediamine during the interim accounting period, among other factors.
Details and amount of extraordinary lossA valuation loss was recognized on shares in a Dutch subsidiary that manufactures meta-xylylenediamine. The amount was not disclosed.
Consolidated / non-consolidatedConsolidated/non-consolidated
Items this document does not state (1)
Dividend forecast revision

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

For the consolidated results, revenue and profit are expected to exceed the previous forecast due to the sustained high prices of crude oil and methanol, improved profitability from passing higher costs through to engineering plastics prices, the effects of price revisions for BT materials used in semiconductor package substrates, and higher sales volumes of chemicals for semiconductors. On a standalone basis, revenue is expected to increase due to the sustained high prices of crude oil and methanol, but net income is expected to fall below the previous forecast due to, among other factors, a valuation loss on shares in a Dutch subsidiary that manufactures meta-xylylenediamine, recognized during the interim accounting period.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Revisions to Earnings Forecasts | Mitsubishi Gas Chemical Company,Inc. (4182) timely disclosure | Komori